Home › Funds › Stonepine Capital Management, LLC › ELOX

Stonepine Capital Management, LLC position in ELOX

ELOXX PHARMACEUTICALS INC · Health Care

Stonepine Capital Management, LLC reported holding 381,977 shares of ELOX (ELOXX PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$5.8M, representing 4.49% of its reported portfolio and ranking #4 among its reported holdings. Stonepine Capital Management, LLC has disclosed ELOX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)381.98K sh
Reported value held$5.85M
Portfolio Weight4.49%
First reportedQ2 2026
Last changeReduce
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Stonepine Capital Management, LLC's ELOX position evolved

Stonepine Capital Management, LLC first disclosed a stake in ELOX in Q2 2026 at 397,160 shares (US$5.5M). The position peaked in Q3 2026 at 381,977 shares, worth US$5.8M. Across 2 filings, Stonepine Capital Management, LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 381,977 shares valued at US$5.8M — a reduction of -15,183 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q2 2026 397.16K $5.51M New
Q3 2026 381.98K $5.85M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ELOX and 13F data

ELOX (ELOXX PHARMACEUTICALS INC) is a Health Care company. 19 other funds we track also report a position in ELOX — the largest reported positions include EcoR1 Capital, LLC (US$5.6M), Samsara BioCapital, LLC (US$5.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ELOX

All ELOX fund holders →

FAQ

How long has Stonepine Capital Management, LLC held ELOX?

Stonepine Capital Management, LLC has disclosed ELOX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Stonepine Capital Management, LLC's current position in ELOX?

As of Q3 2026, Stonepine Capital Management, LLC holds 381.98K shares of ELOX (ELOXX PHARMACEUTICALS INC), valued at $5.85M, representing 4.49% of its reported portfolio and ranking #4.

Has Stonepine Capital Management, LLC been buying or selling ELOX?

In the latest 13F filing (Q3 2026), Stonepine Capital Management, LLC reduced its position in ELOX. The position peaked in Q3 2026 at 381.98K shares.

Which other funds hold ELOX?

Other major institutional holders of ELOX include EcoR1 Capital, LLC, Samsara BioCapital, LLC, among 19 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.